The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Navigating challenges in HPAPI development and manufacturing
Webinar On Demand
High potency active pharmaceutical ingredients (HPAPIs) account for over 50% of today’s small molecule new chemical entity (NCE) drug pipeline. Although they represent a revolutionary pharmaceutical advancement in the areas of oncology treatments and personalized medicine, their development and manufacturing carry inherent risks due to their toxicity levels.
This webinar covers key considerations in developing and manufacturing HPAPIs, including product containment strategies, personnel protection needs, and cross-contamination risks.
Specific webinar key takeaways include:
- The remarkable growth of HPAPIs in the new chemical entity small molecule drug pipeline
- Unique considerations and challenges involved in developing and manufacturing HPAPIs
- The role of product containment, personnel protection, and cross-contamination management
- Insights into specialized facilities and state-of-the-art equipment for handling HPAPIs
- The overall necessity of robust cleaning procedures and verification process requirements
Additionally, viewers will explore how an experienced CDMO partner like Thermo Fisher Scientific can help provide the right knowledge, infrastructure, and commitment to safety that’s needed to help biopharma companies overcome various industry challenges related to HPAPI development and manufacturing.
Watch the on-demand webinar to learn more.